Mark E. Molitch

High Risk of Hypopituitarism after Traumatic Brain Injury: A Prospective Investigation of Anterior Pituitary Function in the Acute Phase and 12 Months after TraumaTanriverdi F, Senyurek H, Unluhizarci K, et al (Erciyes Univ Med School, Kayseri, Turkey; Santiago de Compostela Univ, Spain) J Clin Endocrinol Metab 91:2105–2111, 2006§

The clinical characteristics of headache in patients with pituitary tumoursLevy MJ, Matharu MS, Meeran K, et al (Inst of Neurology, London; National Hosp for Neurology and Neurosurgery, London; Hammersmith/Charing Cross Hospitals Trust, London) Brain 128:1921–1930, 2005§

The Effects of Growth Hormone and/or Testosterone in Healthy Elderly Men: A Randomized Controlled TrialGiannoulis MG, Sonksen PH, Umpleby M, et al (St Thomas' Hosp, London; Univ of London) J Clin Endocrinol Metab 91:477–484, 2006§

Genetic Screening of Combined Pituitary Hormone Deficiency: Experience in 195 PatientsReynaud R, Gueydan M, Saveanu A, et al (Centre Hospitalo Universitaire Timone, Marseille, France; Centre Hospitalo-Universitaire Conception, Marseille, France; Université de la Méditerranée, Marseille, France) J Clin Endocrinol Metab 91:3329–3336, 2006§

Risk for severe hypoglycaemia with unawareness in GH-deficient patients during the insulin tolerance testHolmer H, Link K, Erfurth EM (Lund Univ, Sweden) Clin Endocrinol (Oxf) 64:136–140, 2006§

Biochemical evaluation of disease activity after pituitary surgery in acromegaly: a critical analysis of patients who spontaneously change disease statusEspinosa-de-los-Monteros AL, Sosa E, Cheng S, et al (Instituto Mexicano del Seguro Social, Mexico City) Clin Endocrinol (Oxf) 64:245–249, 2006§

Glucose Homeostasis and Safety in Patients with Acromegaly Converted from Long-Acting Octreotide to PegvisomantBarkan AL, Burman P, Clemmons DR, et al (Univ of Michigan Med Ctr, Ann Arbor; Pfizer, Inc, New York; Univ of North Carolina School of Medicine, Chapel Hill; et al) J Clin Endocrinol Metab 90:5684–5691, 2005§

Effect of protracted treatment with rosiglitazone, a PPARγ agonist, in patients with Cushing's diseaseGiraldi FP, Scaroni C, Arvat E, et al (Univ of Milan, Italy; Univ of Padua, Italy; Univ of Turin, Italy) Clin Endocrinol (Oxf) 64:219–224, 2006§

Loss of constitutive activity of the growth hormone secretagogue receptor in familial short staturePantel J, Legendre M, Cabrol S, et al (Universitaire Henri-Mondor, Créteil, France; Université Paris 12, Créteil, France; Hôpital Armand-Trousseau, Paris; et al) J Clin Invest 116:760–768, 2006§

Human Macroprolactin Displays Low Biological Activity via Its Homologous Receptor in a New Sensitive BioassayGlezer A, Soares CRJ, Vieira JG, et al (Univ of Sao Paulo Med School, Brazil; Instituto de Pesquisas Energeticas e Nucleares-Comissão Nacional de Energia Nuclear, Sao Paulo, Brazil; Fleury Lab, Sao Paulo, Brazil; et al) J Clin Endocrinol Metab 91:1048–1055, 2006§